InvestorsHub Logo
Followers 34
Posts 808
Boards Moderated 0
Alias Born 12/03/2014

Re: None

Sunday, 05/12/2019 11:09:05 PM

Sunday, May 12, 2019 11:09:05 PM

Post# of 163967
Found some more gems while going over the Annual Report again.



Vystar has 3 new versions of Vytex and commenced fulfillment mode for a significant manufacturer of women’s intimate apparel
They are in final testing stages of two of the grades (no ammonia and ultra-low ammonia) as possible replacement for their raw materials

During 2017 and 2018, Vystar contracted with 2 consultants and manufacturers to make exam and surgical gloves on an OEM basis. Testing and results led to further efforts to prepare for a launch of these lines in 2019!
VYST is proceeding with testing and subsequent filing with the USFDA to obtain 501(k) allowances.
With this OEM structure, Vystar will bring several versions (surgical, exam, household, etc) of the gloves to market under its own OEM brand label
Noted- 65% of the total NRL revenue is medical industry sales....medical gloves make up more than 50% of the total market!!
(https://bit.ly/2vWy9XP)


Vytex material can be integrated into current processing environments without additional capital equipment investment. Vytex NRL allows manufacturers to lower manufacturing costs with the benefit of reduced protein levels (reduced leaching times and resulting reductions in energy, water and material handling consumption, leading to realized cost savings)



Overall, think about this. Steve Rotman is a furniture and bedding buy. He's selling all different kinds of materials and comes across Vytex. Steve Rotman saw a product that was out performing and acquired it! As a furniture store owner who sells mattresses, toppers and pillows; he knows his product, knows his consumer and picked Vytex as the best!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYST News